Picture of Solara Active Pharma Sciences logo

SOLARA — Solara Active Pharma Sciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: India's Solara Says Suitability Certificate For Ranitidine Hydrochloride Drug Substance Restored

July 2 (Reuters) - Solara Active Pharma Sciences Ltd
 SOLA.NS :
    * RANITIDINE HYDROCHLORIDE DRUG  SUBSTANCE SUITABILITY
CERTIFICATE
RESTORED BY EUROPEAN MEDICINES QUALITY REGULATOR

Further company coverage:  SOLA.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Solara Active Pharma Sciences

See all news